Kodiak Sciences Inc (NASDAQ:KOD)
| 8.01 Delayed Data As of Jun 28 |  -0.39 / -4.64%Today’s Change | 4.90 Today|||52-Week Range 131.97 | -90.55% Year-to-Date |
Latest KOD News | Press Releases
No recent news for Kodiak Sciences Inc.
Today’s Trading
| Previous close | 8.41 |
| Today’s open | 8.44 |
| Day’s range | 7.92 - 8.56 |
| Volume | 373,929 |
| Average volume (3 months) | 1,649,640 |
| Market cap | $468.1M |
Data as of 4:00pm ET, 06/28/2022
Growth & Valuation
| Earnings growth (last year) | -77.18% |
| Earnings growth (this year) | -29.77% |
| Earnings growth (next 5 years) | +57.40% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.70 |
Competitors
| ---- | ||
| BNGOBionano Genomics Inc | -0.09 | -5.96% |
| PTGXProtagonist Therapeu... | -0.67 | -7.35% |
| ADMAADMA Biologics Inc | -0.14 | -6.48% |
Data as of 3:59pm ET, 06/28/2022
Financials
| Next reporting date | August 16, 2022 |
| EPS forecast (this quarter) | -$1.71 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$267.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Palo Alto, California |
Forecasts
